Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
Open Access
- 30 April 2019
- journal article
- review article
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-13
Abstract
Oligodendrocytes are supporting glial cells that ensure the metabolism and homeostasis of neurons with specific synaptic axoglial interactions in the central nervous system. These require key myelinating glial trophic signals important for growth and metabolism. Thyroid hormone (TH) is one such trophic signal that regulates oligodendrocyte maturation, myelination, and oligodendroglial synaptic dynamics via either genomic or nongenomic pathways. The intracellular and extracellular transport of TH is facilitated by a specific transmembrane transporter known as the monocarboxylate transporter 8 (MCT8). Dysfunction of the MCT8 due to mutation, inhibition, or downregulation during brain development leads to inherited hypomyelination, which manifests as psychomotor retardation in the X-linked inherited Allan-Herndon-Dudley syndrome (AHDS). In particular, oligodendroglial-specific MCT8 deficiency may restrict the intracellular T3availability, culminating in deficient metabolic communication between the oligodendrocytes and the neurons they ensheath, potentially promulgating neurodegenerative adult diseases such as multiple sclerosis (MS). Based on the therapeutic effects exhibited by TH in various preclinical studies, particularly related to its remyelinating potential, TH has now entered the initial stages of a clinical trial to test the therapeutic efficacy in relapsing-remitting MS patients (NCT02506751). However, TH analogs, such as DITPA or Triac, may well serve as future therapeutic options to rescue mature oligodendrocytes and/or promote oligodendrocyte precursor cell differentiation in an environment of MCT8 deficiency within the CNS. This review outlines the therapeutic strategies to overcome the differentiation blockade of oligodendrocyte precursors and maintain mature axoglial interactions in TH-deprived conditions.Keywords
Funding Information
- Bethlehem Griffiths Research Foundation (BGRF1706/1902, 18-0521, 17-0309, 15-022, PA0065, RG4398A1/1)
- Multiple Sclerosis Research Australia (BGRF1706/1902, 18-0521, 17-0309, 15-022, PA0065, RG4398A1/1)
- Multiple Sclerosis Research Australia (BGRF1706/1902, 18-0521, 17-0309, 15-022, PA0065, RG4398A1/1)
- Multiple Sclerosis Research Australia (BGRF1706/1902, 18-0521, 17-0309, 15-022, PA0065, RG4398A1/1)
- International Progressive Multiple Sclerosis Alliance Challenge Award (BGRF1706/1902, 18-0521, 17-0309, 15-022, PA0065, RG4398A1/1)
- National Multiple Sclerosis Society (BGRF1706/1902, 18-0521, 17-0309, 15-022, PA0065, RG4398A1/1)
This publication has 135 references indexed in Scilit:
- Inflammation severely alters thyroid hormone signaling in the central nervous system during experimental allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failureGlia, 2016
- Characterization of glucose‐related metabolic pathways in differentiated rat oligodendrocyte lineage cellsGlia, 2015
- The complex world of oligodendroglial differentiation inhibitorsAnnals of Neurology, 2011
- Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cellsGlia, 2010
- PLP/DM20 Expression and turnover in a transgenic mouse model of pelizaeus‐merzbacher diseaseGlia, 2010
- Pelizaeus–Merzbacher–Like disease presentation of MCT8 mutated male subjectsAnnals of Neurology, 2009
- A PLP splicing abnormality is associated with an unusual presentation of PMDAnnals of Neurology, 2002
- Oligodendrocyte development and thyroid hormoneJournal of Neurobiology, 1999
- Sustained neonatal hyperthyroidism in the rat affects myelination in the central nervous systemJournal of Neuroscience Research, 1998
- Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormoneGlia, 1997